(Q33487561)

27 July 2017

A family study of anticardiolipin antibodies and associated clinical conditions (English)

1 reference

27 July 2017

Goldberg SN

1

1 reference

27 July 2017

Conti-Kelly AM

series ordinal

2

1 reference

27 July 2017

Greco TP

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 November 1995

1 reference

American Journal of Medicine

27 July 2017

1 reference

27 July 2017

99

1 reference

27 July 2017

473-479

1 reference

27 July 2017

5

1 reference

Antiphospholipid antibody syndrome: immunologic and clinical aspects

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Studies in familial systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Familial lupus anticoagulants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Antiphospholipid antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Use of Ranks in One-Criterion Variance Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

The relationship of anticardiolipin antibodies to disease activity in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Anticardiolipin antibodies in patients with rheumatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2980222-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)80222-8

1 reference

27 July 2017

1 reference